BioCentury
ARTICLE | Clinical News

Vivus regulatory update

March 15, 1999 8:00 AM UTC

VVUS received U.S. Patent No. 5,877,216 covering the treatment of female sexual dysfunction using topical formulations of vasodilating agents and steroid hormones. ...